Effectiveness of Ledipasvir/Sofosbuvir and Predictors of Treatment Failure in Members with Hepatitis C Genotype 1 Infection: A Retrospective Cohort Study in a Medicaid Population

BACKGROUND: The primary goal of therapy for patients with chronic hepatitis C virus (HCV) infection is eradication of HCV ribonucleic acid, which is predicted by achievement of sustained virologic response at 12 weeks (SVR12). Ledipasvir/sofosbuvir was approved by the FDA in 2014 and 2015 as a once-...

Descripción completa

Detalles Bibliográficos
Autores principales: Kouris, George, Hydery, Tasmina, Greenwood, Bonnie C., Lavitas, Pavel, Price, Mylissa, Clements, Karen, Alper, Caroline J., Lenz, Kimberly, Jeffrey, Paul L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397688/
https://www.ncbi.nlm.nih.gov/pubmed/29952708
http://dx.doi.org/10.18553/jmcp.2018.24.7.591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397688/
https://www.ncbi.nlm.nih.gov/pubmed/29952708
http://dx.doi.org/10.18553/jmcp.2018.24.7.591

Ejemplares similares